Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Researchers describe 'implausible' chemistry that produces herbicidal compound

Researchers describe 'implausible' chemistry that produces herbicidal compound

June 11, 2009

CHAMPAIGN, Ill. - A soil microbe that uses chemical warfare to fight off competitors employs an unusual chemical pathway in the manufacture of its arsenal, researchers report, making use of an enzyme that can do what no other enzyme is known to do: break a non-activated carbon-carbon bond in a single step.

Their study, appearing this week in the journal Nature, provides the first three-dimensional structure of the enzyme, hydroxyethylphosphonate dioxygenase (HEPD) and proposes a mechanism by which it performs its task.




University of Illinois researchers first reported the enzyme in Nature Chemical Biology in 2007, said Wilfred van der Donk, an author on both papers with microbiologist William Metcalf.

"Our team discovered this very implausible chemical reaction," van der Donk said. "And the more we learned about it the more unusual it became. The enzyme is unusual because it breaks a carbon-carbon bond without needing anything except oxygen."

The study is important because HEPD catalyzes a critical step in the chemical pathway that produces phosphinothricin (PT), a bacterial compound that is widely used as an agricultural herbicide. This compound, which is a component of two top-selling weed killers (Liberty and Basta), is effective when used with transgenic crops that have a PT-resistance gene inserted into their DNA. The resistance gene also comes from the bacteria that produce PT. It allows the bacteria (which belong to the genus Streptomyces) to emit the antibiotic to kill off their competitors without killing themselves. Similarly, corn and other crops that contain the resistance gene are able to withstand PT-based herbicides that kill the weeds around them.

The new findings are part of an ongoing exploration at Illinois of naturally produced molecules that contain carbon-phosphorus (C-P) bonds. Although little understood, these phosphonates (which contain C-P bonds) and phosphinates (with C-P-C bonds) are already widely used in agriculture and medicine. This class of compounds includes the herbicide glyphosate, the osteoporosis treatment alendronate, the antimalarial drug fosmidomycin and the antibiotics fosfomycin, dehydrophos and plumbemycin.

Whether man-made or naturally produced, phosphonates and phosphinates are structurally similar to other compounds used by enzymes in nature. They sometimes bind to the same enzymes and thus can inhibit ordinary cellular processes in bacteria or other organisms. This makes them attractive candidates for the development of new antibiotics, said van der Donk, a principal investigator on the study with Metcalf and biochemistry professor Satish Nair.

Understanding how bacteria synthesize these compounds also enables the scientists to predict how bacteria might develop resistance to any new drugs that are developed, he said.

"Knowing how a compound is made may allow you to make an analog that can overcome that resistance," van der Donk said. "That's the game that's been played with penicillin for the last 40 years. Every time a bacterial strain becomes resistant to one penicillin, scientists tinker with the structure so that the organism is susceptible again."

The researchers hope the new findings will spur the development of much smaller, cheaper and more efficient synthetic catalysts that can also sever C-C bonds in one step.

"Every time we find something new in nature it's an inspiration to see if we can copy that reactivity with a small molecule," van der Donk said.

University of Illinois at Urbana-Champaign



Related Chemical Pathway Current Events and Chemical Pathway News Articles Chemical Pathway Current Events and Chemical Pathway News RSS Chemical Pathway Current Events and Chemical Pathway News RSS
Taking sharper aim at stomach ulcer bacteria
Scientists are reporting discovery of a much sought after crack in the armor of a common microbe that infects the stomachs of one-sixth of the world's population, causing stomach ulcers and other diseases.

Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease.

Researchers identify key proteins needed for ovulation
Researchers from the National Institutes of Health and other institutions have identified in mice two proteins essential for ovulation to take place.

Targeted agent shows promise in biliary cancer study
An experimental agent has shown promising results in people with advanced biliary cancer, according to a multi-institutional clinical trial led by cancer researchers at the Ohio State University.

Scripps research team invents first technique for producing promising anti-leukemia agent
Kapakahines, marine-derived natural products isolated from a South Pacific sponge in trace quantities, have shown anti-leukemia potential, but studies have been all but stalled by kapakahines' lack of availability.

'Stuffy nose' mouse: A promise to help treat 31 million with sinusitis
Mice with inflamed nasal tissue being tested at a Johns Hopkins laboratory may be unable to tell if something smells bad or good, but their sensory deficit is nothing to turn up a nose at.

New approach may render disease-causing staph harmless
Researchers at the University of Illinois helped lead a collaborative effort to uncover a completely new treatment strategy for serious Staphylococcus aureus ("Staph") infections.

Scripps research scientists discover chemical triggers for aggression in mice
The work, reported in an advance, online issue of the journal Nature on December 6, 2007, furthers the broad and important goal of elucidating how the neurological system can detect and respond to specific cues in of a sea of potential triggers.

Obesity found to be a risk factor for multiple myeloma
An obese person is more likely than a lean person to develop multiple myeloma, according to researchers from Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health.

Hopkins scientists link immune response to 'ghost' parasites and severely congested sinuses
Although it's unclear why it's so, scientists at Johns Hopkins have linked a gene that allows for the chemical breakdown of the tough, protective casing that houses insects and worms to the severe congestion and polyp formation typical of chronic sinusitis.
More Chemical Pathway Current Events and Chemical Pathway News Articles
Signal Transduction by Reactive Oxygen and Nitrogen Species: Pathways and Chemical Principles

Signal Transduction by Reactive Oxygen and Nitrogen Species: Pathways and Chemical Principles
by H.J. Forman (Editor), J.M. Fukuto (Editor), M. Torres (Editor)

Since publication of the first edition of this book, (then entitled Oxidative Stress and Signal Transduction), reactive oxygen and nitrogen species (ROS/RNS) have taken center stage in the field of signal transduction. Our understanding of the many signaling pathways that coordinate the cell's response to its environment has made significant strides in the last ten years and evidence is now mounting that the ROS and RNS enzymatically produced by the cells are required for different aspects of the cycle of life from growth to apoptosis. The enzymes responsible for the production of ROS and RNS have been unraveled and the participation of these species in numerous signaling pathways has been documented. The next step is now to identify the targets of ROS and RNS and the mechanisms by which...

  Handbook of Psychopharmacology: Volume 9: Chemical Pathways in the Brain
by Leslie L. & Iversen, Susan D. & Snyder, Solomon H. [Eds]. Iversen (Author)



  Materials: Chemical Pathways Key Stage 3 (Bath Science 5-16)
by Nelson Thornes Ltd (Publisher)



  Chemical Pathways of Metabolism Volume II
by David M. Greenberg (Author)



  Chemical Pathways of Metabolism Volume I
by David M. Greenberg (Author)



  Chemical Pathways (University of Bath/Macmillan Science 5-16 Project)
by Nelson Thornes Ltd (Publisher)



  Handbook of Psychopharmacology: Section 2 (Behavioral Pharmachology in Animals) Volume 9: Chemical Pathways in the Brain
by Leslie Iversen (Editor)



  Non-Formal Kinetics: In Search of Chemical Reaction Pathways (Monographs in Modern Chemistry)
by R. Schmid (Author), V.N. Sapunov (Author)

This book describes the development of a process in which the kinetic data are the starting point, rather than a postulated mechanism that is checked for consistency with the kinetic data. This approach is comparable to the systematic scheme of qualitative analysis of inorganic chemistry. It focuses on the dependence of a reaction rate on the concentrations of the reactants. It also uses the influences of temperature, pressure, substituents, and solvents on the reaction rate and linear free energy relationships as clues to the reaction mechanism.

  Stability of Protein Pharmaceuticals: Part A: Chemical and Physical Pathways of Protein Degradation (Pharmaceutical Biotechnology)
by Tim J. Ahern (Editor), Mark C. Manning (Editor)

Genetics Institute, Inc., Cambridge, Massachusetts. Pharmaceutical Biotechnology, Volume 2. First of a two-part examination of protein instability and methods for preventing or retarding these processes.

  Carl Djerassi: Steroids Made it Possible (Profiles, Pathways, and Dreams)
by Carl Djerassi (Author)

Carl Djerassi, primarily known as the inventor of the birth control pill, also developed many spectroscopic techniques for structure identification, including the earliest applications of mass spectroscopy of ORD/CD to organic chemical structure. His forceful manner and inquisitive mind are reflected in his prose to make this an enjoyable and educational work.

© 2009 BrightSurf.com